Figure 2.
A: Prevalence of methylation at p16, MINT1, MINT2, and MINT31 in HPs, serrated adenomas, tubular adenomas, and carcinomas. B: CIMP status of sporadic HPs and of HPs, serrated adenomas, tubular adenomas, and carcinomas from patients with multiple HPs, large HPs, and hyperplastic polyposis. C: CIMP status of HPs from patients with multiple HPs, large HPs, and hyperplastic polyposis.